Who owns 4D MOLECULAR THERAPEUTICS IN?
- Ticker: FDMT
- CUSIP Number: 35104e100
Tip: Access positions for across all investors
Analyze quarterly positions in 4d Molecular Therapeutics In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of 4d Molecular Therapeutics In stock
Who bought or sold 4D MOLECULAR THERAPEUTICS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 5.1M | $161M | 21% | Mar 2024 |
|
| VR Adviser | 4.4M | $140M | 29% | Mar 2024 |
|
| BlackRock | 4.3M | $137M | 37% | Mar 2024 |
|
| BVF | 3.9M | $125M | -2% | Mar 2024 |
|
| Henderson Group | 3.2M | $102M | 3% | Mar 2024 |
|
| Goldman Sachs Group | 3.1M | $97M | 275% | Mar 2024 |
|
| Viking Global Investors | 2.9M | $94M | -39% | Mar 2024 |
|
| Vanguard Group | 2.3M | $75M | 25% | Mar 2024 |
|
| Morgan Stanley | 1.5M | $49M | 6% | Mar 2024 |
|
| Redmile Group | 1.3M | $40M | 100% | Mar 2024 |
|
| Arrowpoint Asset Management | 1.1M | $34M | -10% | Mar 2024 |
|
| Braidwell | 1.1M | $34M | 100% | Mar 2024 |
|
| FMR | 969k | $31M | 35055% | Mar 2024 |
|
| Geode Capital Management | 873k | $28M | 18% | Mar 2024 |
|
| Casdin Capital | 800k | $26M | -23% | Mar 2024 |
|
| Eventide Asset Management | 776k | $25M | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 749k | $24M | 8% | Mar 2024 |
|
| Ikarian Capital | 515k | $16M | 100% | Mar 2024 |
|
| LMR Partners | 488k | $16M | 100% | Mar 2024 |
|
| Eagle Health Investments | 463k | $15M | 6% | Mar 2024 |
|
| Assenagon Asset Management | 431k | $14M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 403k | $13M | -6% | Mar 2024 |
|
| Voloridge Investment Management | 381k | $12M | 1835% | Mar 2024 |
|
| UBS Group | 374k | $12M | 335% | Mar 2024 |
|
| Northern Trust | 374k | $12M | 3% | Mar 2024 |
|
| Opaleye Management | 344k | $11M | 12% | Mar 2024 |
|
| Charles Schwab Investment Management | 302k | $9.6M | 12% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 269k | $8.6M | 36% | Mar 2024 |
|
| Marshall Wace | 258k | $8.2M | 100% | Mar 2024 |
|
| Integral Health Asset Management | 250k | $8.0M | 100% | Mar 2024 |
|
| Susquehanna International | 221k | $7.0M | 300% | Mar 2024 |
|
| Sofinnova Ventures | 198k | $6.3M | 100% | Mar 2024 |
|
| Soleus Capital Management | 197k | $6.3M | 331% | Mar 2024 |
|
| Rafferty Asset Management | 192k | $6.1M | 19% | Mar 2024 |
|
| Wellington Management Company | 181k | $3.7M | 4% | Dec 2023 |
|
| Citadel Advisors | 166k | $5.3M | 232% | Mar 2024 |
|
| Sphera Funds Management | 162k | $5.2M | 100% | Mar 2024 |
|
| Citigroup | 153k | $4.9M | 271% | Mar 2024 |
|
| Boothbay Fund Management | 150k | $4.8M | 100% | Mar 2024 |
|
| Perigon Wealth Management | 146k | $4.7M | -41% | Mar 2024 |
|
| Zimmer Partners | 139k | $4.4M | 100% | Mar 2024 |
|
| Kennedy Capital Management | 137k | $4.4M | 100% | Mar 2024 |
|
| Bank of New York Mellon | 131k | $4.2M | -9% | Mar 2024 |
|
| Caption Management | 125k | $4.0M | 15% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 122k | $3.9M | -75% | Mar 2024 |
|
| Alyeska Investment Group | 114k | $3.6M | 100% | Mar 2024 |
|
| Nuveen Asset Management | 109k | $3.5M | 1% | Mar 2024 |
|
| Bank of America Corporation | 108k | $3.4M | -35% | Mar 2024 |
|
| PanAgora Asset Management | 102k | $3.3M | -2% | Mar 2024 |
|
| Baker Bros. Advisors | 100k | $3.2M | 100% | Mar 2024 |
|
| Eudaimonia Asset Management | 96k | $3.1M | 100% | Mar 2024 |
|
| Bank Of Montreal | 79k | $2.5M | 206% | Mar 2024 |
|
| Rhumbline Advisers | 64k | $2.0M | 7% | Mar 2024 |
|
| Soros Fund Management | 63k | $2.0M | 100% | Mar 2024 |
|
| PDT Partners | 60k | $1.9M | 100% | Mar 2024 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 55k | $1.1M | -84% | Dec 2023 |
|
| Swiss National Bank | 54k | $1.7M | 30% | Mar 2024 |
|
| Barclays | 48k | $1.5M | -56% | Mar 2024 |
|
| Skandinaviska Enskilda Banken AB | 45k | $1.4M | 100% | Mar 2024 |
|
| D. E. Shaw & Co | 44k | $1.4M | 100% | Mar 2024 |
|
| Platinum Investment Mangement | 41k | $1.3M | 100% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 32k | $1.0M | 36% | Mar 2024 |
|
| Two Sigma Investments | 31k | $1.0M | 100% | Mar 2024 |
|
| Privium Fund Management B.V. | 31k | $988k | -8% | Mar 2024 |
|
| Alliancebernstein | 30k | $611k | -64% | Dec 2023 |
|
| DekaBank Deutsche Girozentrale | 30k | $1.1M | -35% | Mar 2024 |
|
| First Trust Advisors | 30k | $953k | 100% | Mar 2024 |
|
| Jane Street | 30k | $940k | 16% | Mar 2024 |
|
| M^T Bank Corporation | 29k | $935k | -26% | Mar 2024 |
|
| ALPS Advisors | 29k | $588k | 100% | Dec 2023 |
|
| California State Teachers Retirement System | 29k | $908k | 5% | Mar 2024 |
|
| Franklin Resources | 27k | $855k | -49% | Mar 2024 |
|
| State of Wisconsin Investment Board | 26k | $833k | -40% | Mar 2024 |
|
| Peloton Wealth Strategists | 25k | $797k | 0% | Mar 2024 |
|
| ProFund Advisors | 24k | $779k | 16% | Mar 2024 |
|
| Qube Research & Technologies | 24k | $777k | 100% | Mar 2024 |
|
| Credit Suisse | 24k | $765k | 8% | Mar 2024 |
|
| T. Rowe Price Associates | 24k | $764k | 6% | Mar 2024 |
|
| Legal & General Group | 24k | $760k | -3% | Mar 2024 |
|
| Belvedere Trading | 22k | $711k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 21k | $428k | 0% | Dec 2023 |
|
| Mirae Asset Global Investments | 20k | $640k | -7% | Mar 2024 |
|
| American International | 20k | $402k | 2% | Dec 2023 |
|
| Principal Financial Group | 19k | $611k | 92% | Mar 2024 |
|
| Mitsubishi UFJ Asset Management | 19k | $604k | -4% | Mar 2024 |
|
| Hsbc Holdings | 19k | $384k | 100% | Dec 2023 |
|
| Concurrent Investment Advisors | 17k | $552k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 17k | $547k | -12% | Mar 2024 |
|
| Engineers Gate Manager | 17k | $547k | 100% | Mar 2024 |
|
| Sei Investments | 16k | $504k | 100% | Mar 2024 |
|
| Bellevue Group | 16k | $500k | 100% | Mar 2024 |
|
| HighVista Strategies | 16k | $495k | -54% | Mar 2024 |
|
| Squarepoint Ops | 15k | $466k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 14k | $457k | 17% | Mar 2024 |
|
| Ing Investment Management | 13k | $423k | -16% | Mar 2024 |
|
| Millennium Management | 11k | $365k | 100% | Mar 2024 |
|
| ProShare Advisors | 11k | $344k | 100% | Mar 2024 |
|
| New York Life Investment Management | 11k | $334k | 100% | Mar 2024 |
|
| Elmwood Wealth Management | 9.8k | $312k | -51% | Mar 2024 |
|
| China Universal Asset Management | 9.6k | $305k | 93% | Mar 2024 |
|
| Lazard Asset Management | 9.5k | $192k | 315% | Dec 2023 |
|
| Deerfield Management Company | 8.8k | $281k | 100% | Mar 2024 |
|
| Entropy Technologies | 7.5k | $239k | 100% | Mar 2024 |
|
| Arizona State Retirement System | 7.5k | $238k | 100% | Mar 2024 |
|
| DnB NOR Asset Management AS | 7.4k | $234k | 100% | Mar 2024 |
|
| E Fund Management | 7.4k | $234k | 100% | Mar 2024 |
|
| Zurcher Kantonalbank | 5.7k | $183k | 3% | Mar 2024 |
|
| Daiwa Securities Group | 5.6k | $178k | -5% | Mar 2024 |
|
| Virtus ETF Advisers | 5.2k | $166k | -6% | Mar 2024 |
|
| Simplex Trading | 4.7k | $151k | -57% | Mar 2024 |
|
| SG Americas Securities | 4.6k | $146k | -83% | Mar 2024 |
|
| Summit Investment Advisors | 3.9k | $125k | 0% | Mar 2024 |
|
| Allspring Global Investments Holdings | 3.5k | $110k | 702% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 2.6k | $53k | 0% | Dec 2023 |
|
| ADAR1 Capital Management | 2.0k | $64k | 100% | Mar 2024 |
|
| Us Bancorp | 1.9k | $59k | 4% | Mar 2024 |
|
| Royal Bank of Canada | 1.8k | $57k | -86% | Mar 2024 |
|
| NISA Investment Advisors | 1.7k | $53k | 2% | Mar 2024 |
|
| Itau Unibanco Holding | 1.6k | $33k | 10% | Dec 2023 |
|
| Amalgamated Bank | 1.4k | $43k | -65% | Mar 2024 |
|
| Tower Research Capital | 982.00 | $31k | -12% | Mar 2024 |
|
| Pacer Advisors | 729.00 | $23k | 100% | Mar 2024 |
|
| Signature | 601.00 | $19k | 4% | Mar 2024 |
|
| Cutler | 500.00 | $0 | -50% | Mar 2024 |
|
| BFSG | 500.00 | $16k | -67% | Mar 2024 |
|
| White Bay PT | 142.00 | $5.0k | 100% | Mar 2024 |
|
| GAMMA Investing | 77.00 | $2.5k | 38% | Mar 2024 |
|
| Lindbrook Capital | 68.00 | $2.2k | 0% | Mar 2024 |
|
| Parallel Advisors | 33.00 | $1.1k | 0% | Mar 2024 |
|
| Quest Partners | 33.00 | $1.1k | 100% | Mar 2024 |
|
| Hanson McClain Advisors | 28.00 | $893.001200 | 100% | Mar 2024 |
|
| Pnc Financial Services | 28.00 | $891.998800 | -12% | Mar 2024 |
|
| Harbour Investments | 25.00 | $507.000000 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 11.00 | $330.000000 | 0% | Mar 2024 |
|
| Able Wealth Management | 9.00 | $181.999800 | 100% | Dec 2023 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 8.00 | $254.000000 | 100% | Mar 2024 |
|
| Covestor | 4.00 | $0 | 100% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 1.00 | $32.000000 | 100% | Mar 2024 |
|
Who sold out of 4d Molecular Therapeutics In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Dec 2023 | 416k | $8.4M |
| Verition Fund Management | Sep 2023 | 167k | $2.1M |
| First Manhattan | Sep 2023 | 160k | $2.0M |
| Vontobel Holding | Dec 2023 | 143k | $2.9M |
| Laurion Capital Management | Dec 2023 | 53k | $1.1M |
| Trexquant Investment | Sep 2023 | 44k | $566k |
| ExodusPoint Capital Management | Sep 2023 | 29k | $373k |
| Bridgeway Capital Management | Sep 2023 | 27k | $349k |
| Royce & Associates | Dec 2023 | 19k | $380k |
| Aigen Investment Management | Sep 2023 | 17k | $216k |
| Fox Run Management | Sep 2023 | 12k | $155k |
| Florida State Board of Administration | Dec 2023 | 11k | $227k |
| Vident Advisory | Sep 2023 | 11k | $135k |
| Hrt Financial | Dec 2023 | 10k | $202k |
| Sandia Investment Management | Dec 2023 | 4.5k | $91k |
| Advisor Group Holdings | Dec 2023 | 1.6k | $32k |
| Group One Trading | Sep 2023 | 425.00 | $5.4k |
| McGlone Suttner Wealth Management | Dec 2023 | 25.00 | $507.000000 |